Effect of AYUSH 64 in COVID 19
Phase 2
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/06/025855
- Lead Sponsor
- IPGT and RA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
Asymptomatic or minimal symptomatic COVID 19 patients Patients having 0 to 4 score as per the WHO ordinal scale for clinical improvement
Age 18 to 70years
Patients who can take oral medicine
Patients who are ready to give written consent
Exclusion Criteria
Age below 18 and above 70years
Patients having severe symptoms of COVID19
Patients on mechanical ventilator or organ support
Patients do not able to take oral medication
Pregnant and lactating women
Oncological diseases and other systemic uncontrol conditions such as HTN diabetes etc
Liver or kidney malfunctions.
Severe pneumonia Acute respiratory distress syndrome Sepsis and Septic Shock
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ordinal scale for Clinical improvement as per WHO <br/ ><br>Duration on mechanical ventilator <br/ ><br>All cause mortality <br/ ><br>Timepoint: 0 7 14 and 28th day
- Secondary Outcome Measures
Name Time Method Duration on oxygen therapyTimepoint: 0 7 14 and 28th day;Number of cases reporting any ADR AE <br/ ><br>Timepoint: 0 7 14 and 28th day;Number of patients developed symptomsTimepoint: 0 14 and 28th day;Number of patients who needed mechanical ventilatorTimepoint: 0 14 and 28th day;Number of patients who needed oxygen therapyTimepoint: 0 14 and 28th day;Total duration of symptomatic phaseTimepoint: 0 14 and 28th day